Charter
The Emerging Regenerative Medicine Technology (ERMT) Working Group aims to evaluate new innovative therapeutic technologies in addressing current challenges and gap in the development of cell and gene therapies through the lens of process development and biomanufacturing.
The committee will review, inform and discuss issues that are critical for translating towards the clinic for accelerated development of safe and effective cell therapies with an initial focus on iPSC and iPSC-derived cells, and later on other technologies such as tissue engineering and gene editing.
Goals
- Review current challenges and gaps in emerging cell therapy approaches field and inform best practices and methods with proven use
- Discuss emerging manufacturing technologies and their impact on overcoming current bioprocessing bottlenecks
- Coordinate with other ISCT committees to drive consensus and disseminate information though publications and presentations.
Projects & Objectives
- The Working Group is currently exploring iPSC technology
- Webinar: ERMT aims to create a presentation focused on the use of iPSC technology in the field.
- White papers: ERMT is curating a paper on the technology available to reprogram, expand and differentiate iPSCs. The publication is estimated for 2023.